Vernal keratoconjunctivitis (VKC) is a rare form of chronic eye allergy of the ocular surface, and one of the most severe forms of allergic conjunctivitis. It, along with the ocular surface, causes corneal complications such as corneal scars, astigmatism and keratoconus, and if left untreated can result in vision loss. An eye-threatening disease, Vernal keratoconjunctivitis, is characterized by the swollen eyelid, tearing red eyes, mucous discharge, intense itching and photophobia. The most common symptoms of the allergy are giant papillae, superficial keratitis, limbitis, corneal epitheliopathy and conjunctival hyperaemia.
This report aims to provide a comprehensive presentation of the global market for Vernal Keratoconjunctivitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vernal Keratoconjunctivitis. This report contains market size and forecasts of Vernal Keratoconjunctivitis in global, including the following market information:
Global Vernal Keratoconjunctivitis Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Vernal Keratoconjunctivitis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Topical Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Vernal Keratoconjunctivitis include Akari Therapeutics, Allakos, iCo Therapeutics, Santen, Senju Pharmaceutical and Alcon, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vernal Keratoconjunctivitis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vernal Keratoconjunctivitis Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Vernal Keratoconjunctivitis Market Segment Percentages, by Type, 2022 (%)
Topical
Oral
Global Vernal Keratoconjunctivitis Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Vernal Keratoconjunctivitis Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Others
Global Vernal Keratoconjunctivitis Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Vernal Keratoconjunctivitis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vernal Keratoconjunctivitis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Vernal Keratoconjunctivitis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Akari Therapeutics
Allakos
iCo Therapeutics
Santen
Senju Pharmaceutical
Alcon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vernal Keratoconjunctivitis, market overview.
Chapter 2: Global Vernal Keratoconjunctivitis market size in revenue.
Chapter 3: Detailed analysis of Vernal Keratoconjunctivitis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vernal Keratoconjunctivitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Vernal Keratoconjunctivitis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vernal Keratoconjunctivitis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vernal Keratoconjunctivitis Overall Market Size
2.1 Global Vernal Keratoconjunctivitis Market Size: 2022 VS 2030
2.2 Global Vernal Keratoconjunctivitis Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Vernal Keratoconjunctivitis Players in Global Market
3.2 Top Global Vernal Keratoconjunctivitis Companies Ranked by Revenue
3.3 Global Vernal Keratoconjunctivitis Revenue by Companies
3.4 Top 3 and Top 5 Vernal Keratoconjunctivitis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Vernal Keratoconjunctivitis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vernal Keratoconjunctivitis Players in Global Market
3.6.1 List of Global Tier 1 Vernal Keratoconjunctivitis Companies
3.6.2 List of Global Tier 2 and Tier 3 Vernal Keratoconjunctivitis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Vernal Keratoconjunctivitis Market Size Markets, 2022 & 2030
4.1.2 Topical
4.1.3 Oral
4.2 By Type - Global Vernal Keratoconjunctivitis Revenue & Forecasts
4.2.1 By Type - Global Vernal Keratoconjunctivitis Revenue, 2018-2023
4.2.2 By Type - Global Vernal Keratoconjunctivitis Revenue, 2024-2030
4.2.3 By Type - Global Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vernal Keratoconjunctivitis Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Vernal Keratoconjunctivitis Revenue & Forecasts
5.2.1 By Application - Global Vernal Keratoconjunctivitis Revenue, 2018-2023
5.2.2 By Application - Global Vernal Keratoconjunctivitis Revenue, 2024-2030
5.2.3 By Application - Global Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Vernal Keratoconjunctivitis Market Size, 2022 & 2030
6.2 By Region - Global Vernal Keratoconjunctivitis Revenue & Forecasts
6.2.1 By Region - Global Vernal Keratoconjunctivitis Revenue, 2018-2023
6.2.2 By Region - Global Vernal Keratoconjunctivitis Revenue, 2024-2030
6.2.3 By Region - Global Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Vernal Keratoconjunctivitis Revenue, 2018-2030
6.3.2 US Vernal Keratoconjunctivitis Market Size, 2018-2030
6.3.3 Canada Vernal Keratoconjunctivitis Market Size, 2018-2030
6.3.4 Mexico Vernal Keratoconjunctivitis Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Vernal Keratoconjunctivitis Revenue, 2018-2030
6.4.2 Germany Vernal Keratoconjunctivitis Market Size, 2018-2030
6.4.3 France Vernal Keratoconjunctivitis Market Size, 2018-2030
6.4.4 U.K. Vernal Keratoconjunctivitis Market Size, 2018-2030
6.4.5 Italy Vernal Keratoconjunctivitis Market Size, 2018-2030
6.4.6 Russia Vernal Keratoconjunctivitis Market Size, 2018-2030
6.4.7 Nordic Countries Vernal Keratoconjunctivitis Market Size, 2018-2030
6.4.8 Benelux Vernal Keratoconjunctivitis Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Vernal Keratoconjunctivitis Revenue, 2018-2030
6.5.2 China Vernal Keratoconjunctivitis Market Size, 2018-2030
6.5.3 Japan Vernal Keratoconjunctivitis Market Size, 2018-2030
6.5.4 South Korea Vernal Keratoconjunctivitis Market Size, 2018-2030
6.5.5 Southeast Asia Vernal Keratoconjunctivitis Market Size, 2018-2030
6.5.6 India Vernal Keratoconjunctivitis Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Vernal Keratoconjunctivitis Revenue, 2018-2030
6.6.2 Brazil Vernal Keratoconjunctivitis Market Size, 2018-2030
6.6.3 Argentina Vernal Keratoconjunctivitis Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Vernal Keratoconjunctivitis Revenue, 2018-2030
6.7.2 Turkey Vernal Keratoconjunctivitis Market Size, 2018-2030
6.7.3 Israel Vernal Keratoconjunctivitis Market Size, 2018-2030
6.7.4 Saudi Arabia Vernal Keratoconjunctivitis Market Size, 2018-2030
6.7.5 UAE Vernal Keratoconjunctivitis Market Size, 2018-2030
7 Vernal Keratoconjunctivitis Companies Profiles
7.1 Akari Therapeutics
7.1.1 Akari Therapeutics Company Summary
7.1.2 Akari Therapeutics Business Overview
7.1.3 Akari Therapeutics Vernal Keratoconjunctivitis Major Product Offerings
7.1.4 Akari Therapeutics Vernal Keratoconjunctivitis Revenue in Global Market (2018-2023)
7.1.5 Akari Therapeutics Key News & Latest Developments
7.2 Allakos
7.2.1 Allakos Company Summary
7.2.2 Allakos Business Overview
7.2.3 Allakos Vernal Keratoconjunctivitis Major Product Offerings
7.2.4 Allakos Vernal Keratoconjunctivitis Revenue in Global Market (2018-2023)
7.2.5 Allakos Key News & Latest Developments
7.3 iCo Therapeutics
7.3.1 iCo Therapeutics Company Summary
7.3.2 iCo Therapeutics Business Overview
7.3.3 iCo Therapeutics Vernal Keratoconjunctivitis Major Product Offerings
7.3.4 iCo Therapeutics Vernal Keratoconjunctivitis Revenue in Global Market (2018-2023)
7.3.5 iCo Therapeutics Key News & Latest Developments
7.4 Santen
7.4.1 Santen Company Summary
7.4.2 Santen Business Overview
7.4.3 Santen Vernal Keratoconjunctivitis Major Product Offerings
7.4.4 Santen Vernal Keratoconjunctivitis Revenue in Global Market (2018-2023)
7.4.5 Santen Key News & Latest Developments
7.5 Senju Pharmaceutical
7.5.1 Senju Pharmaceutical Company Summary
7.5.2 Senju Pharmaceutical Business Overview
7.5.3 Senju Pharmaceutical Vernal Keratoconjunctivitis Major Product Offerings
7.5.4 Senju Pharmaceutical Vernal Keratoconjunctivitis Revenue in Global Market (2018-2023)
7.5.5 Senju Pharmaceutical Key News & Latest Developments
7.6 Alcon
7.6.1 Alcon Company Summary
7.6.2 Alcon Business Overview
7.6.3 Alcon Vernal Keratoconjunctivitis Major Product Offerings
7.6.4 Alcon Vernal Keratoconjunctivitis Revenue in Global Market (2018-2023)
7.6.5 Alcon Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Vernal Keratoconjunctivitis Market Opportunities & Trends in Global Market
Table 2. Vernal Keratoconjunctivitis Market Drivers in Global Market
Table 3. Vernal Keratoconjunctivitis Market Restraints in Global Market
Table 4. Key Players of Vernal Keratoconjunctivitis in Global Market
Table 5. Top Vernal Keratoconjunctivitis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Vernal Keratoconjunctivitis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Vernal Keratoconjunctivitis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Vernal Keratoconjunctivitis Product Type
Table 9. List of Global Tier 1 Vernal Keratoconjunctivitis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vernal Keratoconjunctivitis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Vernal Keratoconjunctivitis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Vernal Keratoconjunctivitis Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Vernal Keratoconjunctivitis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Vernal Keratoconjunctivitis Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Vernal Keratoconjunctivitis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Vernal Keratoconjunctivitis Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2024-2030
Table 30. Akari Therapeutics Company Summary
Table 31. Akari Therapeutics Vernal Keratoconjunctivitis Product Offerings
Table 32. Akari Therapeutics Vernal Keratoconjunctivitis Revenue (US$, Mn) & (2018-2023)
Table 33. Akari Therapeutics Key News & Latest Developments
Table 34. Allakos Company Summary
Table 35. Allakos Vernal Keratoconjunctivitis Product Offerings
Table 36. Allakos Vernal Keratoconjunctivitis Revenue (US$, Mn) & (2018-2023)
Table 37. Allakos Key News & Latest Developments
Table 38. iCo Therapeutics Company Summary
Table 39. iCo Therapeutics Vernal Keratoconjunctivitis Product Offerings
Table 40. iCo Therapeutics Vernal Keratoconjunctivitis Revenue (US$, Mn) & (2018-2023)
Table 41. iCo Therapeutics Key News & Latest Developments
Table 42. Santen Company Summary
Table 43. Santen Vernal Keratoconjunctivitis Product Offerings
Table 44. Santen Vernal Keratoconjunctivitis Revenue (US$, Mn) & (2018-2023)
Table 45. Santen Key News & Latest Developments
Table 46. Senju Pharmaceutical Company Summary
Table 47. Senju Pharmaceutical Vernal Keratoconjunctivitis Product Offerings
Table 48. Senju Pharmaceutical Vernal Keratoconjunctivitis Revenue (US$, Mn) & (2018-2023)
Table 49. Senju Pharmaceutical Key News & Latest Developments
Table 50. Alcon Company Summary
Table 51. Alcon Vernal Keratoconjunctivitis Product Offerings
Table 52. Alcon Vernal Keratoconjunctivitis Revenue (US$, Mn) & (2018-2023)
Table 53. Alcon Key News & Latest Developments
List of Figures
Figure 1. Vernal Keratoconjunctivitis Segment by Type in 2022
Figure 2. Vernal Keratoconjunctivitis Segment by Application in 2022
Figure 3. Global Vernal Keratoconjunctivitis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Vernal Keratoconjunctivitis Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Vernal Keratoconjunctivitis Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vernal Keratoconjunctivitis Revenue in 2022
Figure 8. By Type - Global Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 9. By Application - Global Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 10. By Type - Global Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 12. By Application - Global Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 14. By Region - Global Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 15. By Country - North America Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 16. US Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 20. Germany Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 21. France Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 28. China Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 32. India Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 34. Brazil Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Vernal Keratoconjunctivitis Revenue Market Share, 2018-2030
Figure 37. Turkey Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Vernal Keratoconjunctivitis Revenue, (US$, Mn), 2018-2030
Figure 41. Akari Therapeutics Vernal Keratoconjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Allakos Vernal Keratoconjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. iCo Therapeutics Vernal Keratoconjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Santen Vernal Keratoconjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Senju Pharmaceutical Vernal Keratoconjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Alcon Vernal Keratoconjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
